Navigation Links
Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results
Date:1/18/2013

THOUSAND OAKS, Calif., Jan. 18, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will report its fourth quarter and full year 2012 financial results on Wednesday, Jan. 23, 2013, after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. Pacific Standard Time. Participating in the call from Amgen will be Robert A. Bradway , chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public.

The webcast of the conference, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 30 days after the event.  

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people'
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amgen Highlights Data To Be Presented At American Society of Hematology Annual Meeting
2. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
3. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
4. Amgen Announces 2012 Third Quarter Dividend
5. Amgen to Present at the Leerink Swann Global Healthcare Conference
6. Amgen to Acquire Micromet
7. Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
10. Amgen Announces 2012 First Quarter Dividend
11. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 The University of ... Max Planck Society establishing the Max Planck-University ... center will link two of the world's foremost research ... only the third Max Planck Centre in North America. ... for optics and photonics, was with university and ...
(Date:5/26/2015)... 26, 2015 Innovacyn, a leader ... the human and animal health industries, announced today ... Innovators of Agriculture College Scholarship Award. The scholarship ... exhibits a passionate commitment to the agriculture industry ... year’s winners, Alexis Pedrow from Anderson County Jr/Sr ...
(Date:5/26/2015)... May 26, 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... and CEO, will provide an update on the progress of ... of the company,s business strategy at 1:30pm ET on Monday, ... The conference is being held in New York, ... live and may be accessed via a link on the ...
(Date:5/26/2015)... 26, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... Company,s Annual Meeting of Shareholders for fiscal year ended ... at the Company,s office located in Chengdu, ... AM (local time in Chengdu, China ...
Breaking Biology Technology:Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 2Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 3Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3
... a lot of excitement a few years ago following ... could be used to build nanoparticles of a given ... remained out of reach. An international team of researchers ... and Professor Friedrich Simmel of the Technische Universitaet Muenchen ...
... 2012 The Foundation of UMDNJ, an affiliate of ... biomarkers grant through the Bill & Melinda Gates Foundation,s ... seeks to overcome persistent bottlenecks in creating new tools ... With the grant, Dr. David Alland, ...
... United Arab Emirates   is the First Country in ... Allergy Sufferers - Nycomed, a Takeda company, ... in the United Arab Emirates for the treatment of allergic ... adults and adolescents over the age of 12.   ...
Cached Biology Technology:Nano spiral staircases modify light 2Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant 2Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant 3Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis 2Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis 3Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis 4
(Date:5/22/2015)... 22, 2015 According to a ... (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), by ... Utilities, Consumer and Home) - Global Forecast to 2020", ... $2.77 Billion in 2015 to $6.19 Billion by 2020, ... 79 market data Tables and   43 Figures spread ...
(Date:5/19/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... NEW ORLEANS Three and a half years after ... and sustained use of genetically engineered T cells to ... of Medicine at the University of Pennsylvania and the ... results of studies involving both adults and children with ...
... can have beneficial health effects, scientists have sought to ... A new study by researchers in Wisconsin, Spain, and ... in the body following a period of mindfulness meditation. ... of intensive mindfulness practice in a group of experienced ...
... pulses support the idea that intuition-defying quantum interactions between ... light to fuel their growth. But key details of ... role that quantum physics may play in understanding them ... an Overview Article in the January issue of ...
Cached Biology News:Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy 2Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy 3Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy 4Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy 5Study reveals gene expression changes with meditation 2Study reveals gene expression changes with meditation 3Quantum effects help cells capture light, but the details are obscure 2
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
... TAMRA isomers are predominantly used for labeling ... for labeling peptides and nucleotides because they ... is often required in the conjugation processes. ... for labeling peptides and proteins. 6-TAMRA is ...
anti-Lactate Dehydrogenase...
Mouse monoclonal [6E10] to LAP2 ( Abpromise for all tested applications). entrezGeneID: 7112 SwissProtID: P42166...
Biology Products: